The Role of Mitochondrial Redox Regulations in Inflammation and Disease

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".

Deadline for manuscript submissions: 31 July 2024 | Viewed by 237

Special Issue Editor


E-Mail Website
Guest Editor
Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK
Interests: mitochondria; energy metabolism; neurodegeneration; Alzheimer’s disease; Parkinson’s disease; misfolded proteins; calcium homeostasis; calcium signaling; oxidative stress; ferroptosis; ROS signaling; epilepsy; ischemia; hypoxia; cancer; brain inorganic polyphosphate
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Redox-dependent processes regulate most of the cellular functions, such as proliferation, differentiation, and apoptosis. Mitochondria are cellular organelles with a pivotal role in many cellular processes, including the production and distribution of energy for all cellular functions, controlling the processes of quality control, protein transport, and biogenesis and programmed cell death, and the regulation of metabolic pathways, ionic homeostasis, thermogenesis, stress responses, cellular signaling, and inflammatory response. Mitochondria, on the one hand, generate reactive oxygen species (ROS) that drive redox-sensitive events and, on the other hand, respond to ROS-mediated changes in the cellular redox state. Therefore, any disruption of mitochondrial function is central to the development of a wide range of major human diseases.

This Special Issue is devoted to providing the latest insights into the role of mitochondrial redox regulation in the molecular mechanisms of mitochondrial redox signalling, the impact of mitochondrial dysfunction on cellular metabolism and inflammation, the role of mitochondrial redox regulation in the pathogenesis of various diseases such as cancer, cardiovascular disease and neurodegenerative disorders and the potential therapeutic implications of targeting mitochondrial redox signalling for the treatment of these diseases.

Dr. Plamena R. Angelova
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • redox signalling
  • mitochondrial dysfunction
  • mitochondrial bioenergetics
  • mitochondrial dynamics
  • mitochondrial biogenesis
  • oxidative stress
  • inflammation
  • cancer
  • diabetes
  • neurodegeneration
  • cardiovascular diseases
  • ischemia-reperfusion injury

Published Papers

This special issue is now open for submission.
Back to TopTop